Astria Therapeutics to Participate in Upcoming Oppenheimer Innovators in Immunology ' Inflammation Summit - Business Wire
  Connect Biopharma Presents Data Supporting Rademikibart at - GlobeNewswire
  Editors resign from Springer immunology journal to launch nonprofit title - Retraction Watch
  A Norwegian cohort with STAT1-related diseasefurther expanding the clinical phenotype - Frontiers
  Astria Therapeutics Announces Positive Initial Results from the ALPHA-SOLAR Long-Term Open-Label Trial of Navenibart in Hereditary Angioedema Patients at the European Academy of Allergy and Clinical Immunology Annual Congress - Yahoo Finance
  Revolutionary Gene Therapy Eliminates HAE Attacks for 2 Years: Breakthrough Phase 1 Trial Results - Stock Titan
  KalVista Pharmaceuticals Presents New Data at the European Academy of Allergy and Clinical Immunology Congress 2025 on the Efficacy of Sebetralstat for the On-demand Treatment of HAE Attacks Among Patients Receiving Long-Term Prophylaxis - Business Wire
  Stopping asthma in its tracks - La Jolla Institute